Baxter Intl Inc Financials
Baxter Intl Inc (BAX) reported $11.2B in revenue for fiscal year 2025, up 5.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Margin compression is overwhelming revenue recovery, leaving Baxter cash-generative but less profitable and financially less flexible.
Revenue reached$11.2B in FY2025, but gross margin fell to30.1% , indicating the top-line recovery did not restore the economics of each sales dollar. Compared with FY2023's40.1% gross margin, FY2025's-2.7% operating margin shows the pressure extends beyond production costs into the broader operating structure.
FY2025's net loss of
Long-term debt fell to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Baxter Intl Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Baxter Intl Inc has an operating margin of -2.7%, meaning the company loses $3 on every $100 of revenue. This results in a profitability score of 29/100. This is down from 0.1% the prior year.
Baxter Intl Inc's revenue grew 5.7% year-over-year to $11.2B, a solid pace of expansion. This earns a growth score of 47/100.
Baxter Intl Inc has elevated debt relative to equity (D/E of 1.55), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 4/100, reflecting increased financial risk.
With a current ratio of 2.31, Baxter Intl Inc holds $2.31 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 65/100.
Baxter Intl Inc has a free cash flow margin of 2.9%, earning a moderate score of 50/100. The company generates positive cash flow after capital investments, but with room for improvement.
Baxter Intl Inc posts a -15.6% return on equity (ROE), meaning it loses $16 for every $100 of shareholders' equity. This results in a returns score of 28/100. This is down from -9.3% the prior year.
Baxter Intl Inc scores 2.29, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Baxter Intl Inc passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Baxter Intl Inc reported a net loss of $957.0M while generating $845.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Baxter Intl Inc reported an operating loss of $308.0M against $290.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Baxter Intl Inc generated $11.2B in revenue in fiscal year 2025. This represents an increase of 5.7% from the prior year.
Baxter Intl Inc's EBITDA was $673.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 33.4% from the prior year.
Baxter Intl Inc reported -$957.0M in net income in fiscal year 2025. This represents a decrease of 47.5% from the prior year.
Baxter Intl Inc earned -$1.87 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 47.2% from the prior year.
Cash & Balance Sheet
Baxter Intl Inc generated $332.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 42.1% from the prior year.
Baxter Intl Inc held $2.0B in cash against $9.5B in long-term debt as of fiscal year 2025.
Baxter Intl Inc paid $0.52 per share in dividends in fiscal year 2025. This represents a decrease of 50.0% from the prior year.
Margins & Returns
Baxter Intl Inc's gross margin was 30.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 7.4 percentage points from the prior year.
Baxter Intl Inc's operating margin was -2.7% in fiscal year 2025, reflecting core business profitability. This is down 2.9 percentage points from the prior year.
Baxter Intl Inc's net profit margin was -8.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 2.4 percentage points from the prior year.
Baxter Intl Inc's ROE was -15.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 6.3 percentage points from the prior year.
Capital Allocation
Baxter Intl Inc invested $518.0M in research and development in fiscal year 2025. This represents a decrease of 12.2% from the prior year.
Baxter Intl Inc invested $513.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 15.0% from the prior year.
Not reported for fiscal year 2025.
BAX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.5B | $11.2B+5.7% | $10.6B+2.7% | $10.4B+3.0% | $10.1B-17.2% | $12.1B+4.1% | $11.7B+2.7% | $11.4B+2.4% | $11.1B+4.9% | $10.6B+4.1% | $10.2B+2.0% | $10.0B-7.0% | $10.7B+13.9% | $9.4B-32.5% | $13.9B+0.3% | $13.9B |
| Cost of Revenue | $8.0B | $7.9B+18.2% | $6.7B+7.1% | $6.2B-4.6% | $6.5B-12.4% | $7.4B+4.8% | $7.1B+7.3% | $6.6B+4.1% | $6.3B+3.8% | $6.1B+1.0% | $6.0B+4.7% | $5.8B-5.9% | $6.1B+16.9% | $5.3B-22.8% | $6.8B-0.7% | $6.8B |
| Gross Profit | $3.5B | $3.4B-15.2% | $4.0B-4.0% | $4.2B+16.9% | $3.5B-24.8% | $4.7B+2.9% | $4.6B-3.7% | $4.8B0.0% | $4.8B+6.4% | $4.5B+8.7% | $4.1B-1.8% | $4.2B-8.5% | $4.6B+10.1% | $4.2B-41.7% | $7.1B+1.2% | $7.0B |
| R&D Expenses | $512.0M | $518.0M-12.2% | $590.0M+13.9% | $518.0M+15.1% | $450.0M-15.3% | $531.0M+1.9% | $521.0M-12.4% | $595.0M-9.0% | $654.0M+6.3% | $615.0M-4.8% | $646.0M+10.1% | $587.0M-3.8% | $610.0M+4.8% | $582.0M-46.2% | $1.1B+14.3% | $946.0M |
| SG&A Expenses | $2.9B | $2.9B-2.6% | $3.0B+0.5% | $3.0B-4.6% | $3.1B+8.9% | $2.8B+15.2% | $2.5B-2.6% | $2.5B-3.2% | $2.6B-0.3% | $2.6B-3.6% | $2.7B-10.1% | $3.0B-8.6% | $3.3B+7.5% | $3.1B-6.1% | $3.3B+4.1% | $3.2B |
| Operating Income | -$274.0M | -$308.0M-2300.0% | $14.0M-98.0% | $707.0M+124.9% | -$2.8B-310.7% | $1.4B-16.5% | $1.6B-8.8% | $1.8B+11.9% | $1.6B+23.0% | $1.3B+72.9% | $745.0M+30.0% | $573.0M-12.7% | $656.0M+32.3% | $496.0M | N/A | N/A |
| Interest Expense | $296.0M | $290.0M-28.9% | $408.0M-19.7% | $508.0M+23.0% | $413.0M+99.5% | $207.0M+35.3% | $153.0M+37.8% | $111.0M+19.4% | $93.0M+9.4% | $85.0M-4.5% | $89.0M-39.0% | $146.0M-12.6% | $167.0M+7.7% | $155.0M+37.2% | $113.0M+22.8% | $92.0M |
| Income Tax | $485.0M | $395.0M+967.6% | $37.0M-39.3% | $61.0M+145.2% | -$135.0M-262.7% | $83.0M-54.4% | $182.0M+543.9% | -$41.0M-163.1% | $65.0M-86.8% | $491.0M+4191.7% | -$12.0M-134.3% | $35.0M+6.1% | $33.0M-45.0% | $60.0M-89.2% | $555.0M+0.4% | $553.0M |
| Net Income | -$1.1B | -$957.0M-47.5% | -$649.0M-124.4% | $2.7B+209.2% | -$2.4B-289.5% | $1.3B+16.5% | $1.1B+10.1% | $1.0B-35.3% | $1.5B+156.8% | $602.0M-87.9% | $5.0B+412.9% | $968.0M-61.2% | $2.5B+24.1% | $2.0B-13.5% | $2.3B+4.6% | $2.2B |
| EPS (Diluted) | — | -$1.87-47.2% | -$1.27-124.3% | $5.23+208.3% | -$4.83-290.9% | $2.53+18.8% | $2.13+10.4% | $1.93-31.8% | $2.83+162.0% | $1.08-88.0% | $9.01+411.9% | $1.76-61.4% | $4.56+24.6% | $3.66-12.4% | $4.18+7.7% | $3.88 |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
BAX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.1B-22.2% | $25.8B-8.8% | $28.3B0.0% | $28.3B-15.6% | $33.5B+67.4% | $20.0B+10.0% | $18.2B+15.7% | $15.7B-8.1% | $17.1B+10.1% | $15.5B-25.8% | $21.0B-19.8% | $26.1B+3.6% | $25.2B+23.7% | $20.4B+6.9% | $19.1B |
| Current Assets | $6.9B-22.4% | $8.9B-7.8% | $9.6B+19.8% | $8.0B-9.7% | $8.9B+5.5% | $8.4B+12.1% | $7.5B+25.9% | $6.0B-18.0% | $7.3B+10.5% | $6.6B-44.3% | $11.8B+16.1% | $10.2B-0.3% | $10.2B+10.1% | $9.3B+7.1% | $8.7B |
| Cash & Equivalents | $2.0B+11.5% | $1.8B-42.7% | $3.1B+89.9% | $1.6B-45.1% | $3.0B-20.9% | $3.7B+11.8% | $3.3B+81.4% | $1.8B-45.8% | $3.4B+21.2% | $2.8B+26.6% | $2.2B-24.3% | $2.9B+7.0% | $2.7B-16.4% | $3.3B+12.6% | $2.9B |
| Inventory | $2.2B+9.1% | $2.0B+6.7% | $1.9B-28.4% | $2.7B+9.2% | $2.5B+28.0% | $1.9B+15.9% | $1.7B-0.8% | $1.7B+13.0% | $1.5B+3.1% | $1.4B-10.8% | $1.6B+1.7% | $1.6B-54.9% | $3.5B+24.8% | $2.8B+6.7% | $2.6B |
| Accounts Receivable | $1.9B+10.8% | $1.7B-2.3% | $1.7B-33.1% | $2.6B-2.2% | $2.6B+31.0% | $2.0B+5.9% | $1.9B+3.0% | $1.8B+8.2% | $1.7B | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $4.9B-6.6% | $5.3B-8.9% | $5.8B-10.2% | $6.5B-34.4% | $9.8B+205.8% | $3.2B+6.2% | $3.0B+0.9% | $3.0B-3.2% | $3.1B+19.5% | $2.6B-3.4% | $2.7B-8.2% | $2.9B-11.0% | $3.3B+31.5% | $2.5B+8.0% | $2.3B |
| Total Liabilities | $14.0B-25.6% | $18.8B-5.3% | $19.8B-11.5% | $22.4B-8.2% | $24.4B+116.1% | $11.3B+9.8% | $10.3B+30.9% | $7.9B-1.8% | $8.0B+10.2% | $7.3B-40.1% | $12.1B-32.8% | $18.0B+7.5% | $16.8B+24.6% | $13.5B+7.7% | $12.5B |
| Current Liabilities | $3.0B-54.4% | $6.5B+0.1% | $6.5B+37.0% | $4.7B+12.0% | $4.2B+27.1% | $3.3B+3.2% | $3.2B+14.8% | $2.8B-0.2% | $2.8B+2.8% | $2.7B-52.3% | $5.8B-4.8% | $6.0B+15.0% | $5.2B+10.3% | $4.8B-2.0% | $4.9B |
| Long-Term Debt | $9.5B-8.7% | $10.4B-6.4% | $11.1B-27.2% | $15.2B-11.2% | $17.1B+196.4% | $5.8B+20.3% | $4.8B+38.1% | $3.5B-0.8% | $3.5B+26.3% | $2.8B-29.1% | $3.9B-46.5% | $7.3B-9.8% | $8.1B+45.6% | $5.6B+17.5% | $4.7B |
| Total Equity | $6.1B-12.0% | $7.0B-17.1% | $8.4B+44.0% | $5.8B-35.7% | $9.1B+4.5% | $8.7B+10.2% | $7.9B+0.5% | $7.8B-14.0% | $9.1B+10.1% | $8.3B-6.3% | $8.8B+8.9% | $8.1B-4.1% | $8.5B+22.0% | $6.9B+5.4% | $6.6B |
| Retained Earnings | $13.7B-8.2% | $14.9B-7.4% | $16.1B+14.7% | $14.1B-17.7% | $17.1B+4.5% | $16.3B+3.9% | $15.7B+4.3% | $15.1B+4.1% | $14.5B+2.0% | $14.2B+46.6% | $9.7B-26.8% | $13.2B+11.6% | $11.9B+8.9% | $10.9B+15.5% | $9.4B |
BAX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $845.0M-17.1% | $1.0B-41.0% | $1.7B+42.5% | $1.2B-45.5% | $2.2B+19.0% | $1.9B-11.2% | $2.1B+4.3% | $2.0B+17.7% | $1.7B+3.6% | $1.7B-6.6% | $1.8B-44.9% | $3.2B+0.5% | $3.2B+3.0% | $3.1B+10.3% | $2.8B |
| Capital Expenditures | N/A | $513.0M+15.0% | $446.0M+3.2% | $432.0M+14.6% | $377.0M-45.4% | $691.0M-2.5% | $709.0M+1.9% | $696.0M+5.6% | $659.0M+7.0% | $616.0M-14.3% | $719.0M-21.1% | $911.0M-1.5% | $925.0M+31.0% | $706.0M-39.2% | $1.2B+20.9% | $960.0M |
| Free Cash Flow | N/A | $332.0M-42.1% | $573.0M-55.7% | $1.3B+55.2% | $834.0M-45.5% | $1.5B+32.1% | $1.2B-17.7% | $1.4B+3.7% | $1.4B+23.7% | $1.1B+17.4% | $935.0M+8.7% | $860.0M-62.4% | $2.3B-8.1% | $2.5B+28.1% | $1.9B+4.7% | $1.9B |
| Investing Cash Flow | -$559.0M | $2.8B+553.8% | -$626.0M-119.5% | $3.2B+445.1% | -$931.0M+91.7% | -$11.2B-850.0% | -$1.2B-7.2% | -$1.1B-20.1% | -$916.0M+29.1% | -$1.3B-80.7% | -$715.0M+60.4% | -$1.8B-17.2% | -$1.5B+71.2% | -$5.4B-241.7% | -$1.6B-10.0% | -$1.4B |
| Financing Cash Flow | -$270.0M | -$4.2B-290.0% | -$1.1B+69.0% | -$3.5B-142.6% | -$1.4B-117.4% | $8.2B+2489.9% | -$345.0M-169.3% | $498.0M+119.1% | -$2.6B-2898.9% | $93.0M+128.7% | -$324.0M+32.6% | -$481.0M+65.7% | -$1.4B-185.2% | $1.6B+247.5% | -$1.1B+1.9% | -$1.1B |
| Dividends Paid | $184.0M | $348.0M-41.0% | $590.0M+0.7% | $586.0M+2.3% | $573.0M+8.1% | $530.0M+12.1% | $473.0M+11.8% | $423.0M+12.5% | $376.0M+19.4% | $315.0M+17.5% | $268.0M-70.5% | $910.0M-16.9% | $1.1B+7.0% | $1.0B+27.2% | $804.0M+13.4% | $709.0M |
| Share Buybacks | N/A | N/A | $0 | $0-100.0% | $32.0M-94.7% | $600.0M+20.0% | $500.0M-60.6% | $1.3B-48.2% | $2.5B+334.8% | $564.0M+93.2% | $292.0M | N/A | $550.0M-39.8% | $913.0M-38.3% | $1.5B-6.5% | $1.6B |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
BAX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 30.0%-7.4pp | 37.5%-2.6pp | 40.1%+4.8pp | 35.3%-3.6pp | 38.9%-0.4pp | 39.3%-2.6pp | 41.9%-1.0pp | 42.9%+0.6pp | 42.3%+1.8pp | 40.5%-1.5pp | 42.0%-0.7pp | 42.7%-1.5pp | 44.2%-7.0pp | 51.2%+0.5pp | 50.7% |
| Operating Margin | -2.7%-2.9pp | 0.1%-6.7pp | 6.8%+35.1pp | -28.3%-39.4pp | 11.1%-2.7pp | 13.8%-1.8pp | 15.6%+1.3pp | 14.3%+2.1pp | 12.2%+4.8pp | 7.3%+1.6pp | 5.8%-0.4pp | 6.1%+0.9pp | 5.3% | N/A | N/A |
| Net Margin | -8.5%-2.4pp | -6.1%-31.7pp | 25.6%+49.8pp | -24.2%-34.8pp | 10.6%+1.1pp | 9.4%+0.6pp | 8.8%-5.1pp | 13.9%+8.2pp | 5.7%-43.2pp | 48.9%+39.1pp | 9.7%-13.6pp | 23.3%+1.9pp | 21.4%+4.7pp | 16.7%+0.7pp | 16.0% |
| Return on Equity | -15.6%-6.3pp | -9.3%-40.9pp | 31.6%+73.3pp | -41.7%-55.9pp | 14.1%+1.5pp | 12.7%0.0pp | 12.7%-7.0pp | 19.7%+13.1pp | 6.6%-53.3pp | 59.9%+48.9pp | 10.9%-19.8pp | 30.8%+7.0pp | 23.8%-9.8pp | 33.5%-0.2pp | 33.8% |
| Return on Assets | -4.8%-2.3pp | -2.5%-11.9pp | 9.4%+18.0pp | -8.6%-12.4pp | 3.8%-1.7pp | 5.5%0.0pp | 5.5%-4.3pp | 9.8%+6.3pp | 3.5%-28.4pp | 31.9%+27.3pp | 4.6%-4.9pp | 9.6%+1.6pp | 8.0%-3.4pp | 11.4%-0.3pp | 11.7% |
| Current Ratio | 2.31+1.0x | 1.36-0.1x | 1.48-0.2x | 1.69-0.4x | 2.09-0.4x | 2.52+0.2x | 2.32+0.2x | 2.12-0.5x | 2.57+0.2x | 2.40+0.3x | 2.05+0.4x | 1.68-0.3x | 1.940.0x | 1.95+0.2x | 1.78 |
| Debt-to-Equity | 1.55+0.1x | 1.49+0.2x | 1.32-1.3x | 2.61+0.7x | 1.89+1.2x | 0.67+0.1x | 0.61+0.2x | 0.44+0.1x | 0.380.0x | 0.34-0.1x | 0.44-0.5x | 0.90-0.1x | 0.96+0.2x | 0.80+0.1x | 0.72 |
| FCF Margin | 2.9%-2.4pp | 5.4%-7.1pp | 12.5%+4.2pp | 8.3%-4.3pp | 12.6%+2.7pp | 9.9%-2.5pp | 12.4%+0.2pp | 12.2%+1.9pp | 10.4%+1.2pp | 9.2%+0.6pp | 8.6%-12.7pp | 21.4%-5.1pp | 26.5%+12.5pp | 14.0%+0.6pp | 13.4% |
Similar Companies
Where Baxter Intl Inc Ranks
Frequently Asked Questions
What is Baxter Intl Inc's annual revenue?
Baxter Intl Inc (BAX) reported $11.2B in total revenue for fiscal year 2025. This represents a 5.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Baxter Intl Inc's revenue growing?
Baxter Intl Inc (BAX) revenue grew by 5.7% year-over-year, from $10.6B to $11.2B in fiscal year 2025.
Is Baxter Intl Inc profitable?
No, Baxter Intl Inc (BAX) reported a net income of -$957.0M in fiscal year 2025, with a net profit margin of -8.5%.
What is Baxter Intl Inc's EBITDA?
Baxter Intl Inc (BAX) had EBITDA of $673.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Baxter Intl Inc have?
As of fiscal year 2025, Baxter Intl Inc (BAX) had $2.0B in cash and equivalents against $9.5B in long-term debt.
What is Baxter Intl Inc's gross margin?
Baxter Intl Inc (BAX) had a gross margin of 30.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Baxter Intl Inc's operating margin?
Baxter Intl Inc (BAX) had an operating margin of -2.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Baxter Intl Inc's net profit margin?
Baxter Intl Inc (BAX) had a net profit margin of -8.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Baxter Intl Inc pay dividends?
Yes, Baxter Intl Inc (BAX) paid $0.52 per share in dividends during fiscal year 2025.
What is Baxter Intl Inc's return on equity (ROE)?
Baxter Intl Inc (BAX) has a return on equity of -15.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Baxter Intl Inc's free cash flow?
Baxter Intl Inc (BAX) generated $332.0M in free cash flow during fiscal year 2025. This represents a -42.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Baxter Intl Inc's operating cash flow?
Baxter Intl Inc (BAX) generated $845.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Baxter Intl Inc's total assets?
Baxter Intl Inc (BAX) had $20.1B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Baxter Intl Inc's capital expenditures?
Baxter Intl Inc (BAX) invested $513.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Baxter Intl Inc spend on research and development?
Baxter Intl Inc (BAX) invested $518.0M in research and development during fiscal year 2025.
What is Baxter Intl Inc's current ratio?
Baxter Intl Inc (BAX) had a current ratio of 2.31 as of fiscal year 2025, which is generally considered healthy.
What is Baxter Intl Inc's debt-to-equity ratio?
Baxter Intl Inc (BAX) had a debt-to-equity ratio of 1.55 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Baxter Intl Inc's return on assets (ROA)?
Baxter Intl Inc (BAX) had a return on assets of -4.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Baxter Intl Inc's Altman Z-Score?
Baxter Intl Inc (BAX) has an Altman Z-Score of 2.29, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Baxter Intl Inc's Piotroski F-Score?
Baxter Intl Inc (BAX) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Baxter Intl Inc's earnings high quality?
Baxter Intl Inc (BAX) reported a net loss of $957.0M while generating $845.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Baxter Intl Inc cover its interest payments?
Baxter Intl Inc (BAX) reported an operating loss of $308.0M against $290.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Baxter Intl Inc?
Baxter Intl Inc (BAX) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.